Major Adverse Drug Reactions in Psychiatry

Key points
- This section describes a group of major adverse reactions associated with use of psychiatric medications.
- Dystonia is a neuroleptic-induced movement disorder characterized by muscle spasms.
- Akathisia, a common side effect produced by antipsychotic medications, is also caused by serotonin reuptake inhibitors.
- Minor adverse reactions and side effects are outlined on the pages of the respective medications.
This section describes a group of major adverse reactions associated with use of psychiatric medications. Minor adverse reactions and side effects are outlined on the pages of the respective medications. Although the adverse drug reactions discussed below (with the exception of serotonin syndrome) are most commonly produced by antipsychotic medications, they may occur in response to other medications. The major adverse drug reactions to antipsychotics, their risk factors, onset, and treatment are outlined in Table 16-1. Although the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, classifies dystonia, akathisia, extrapyramidal symptoms (EPS), neuroleptic malignant syndrome (NMS), and tardive dyskinesia as neuroleptic-induced movement disorders, it is clear that akathisia can occur with the use of nonneuroleptic psychiatric medications.
Dystonia
Dystonia is a neuroleptic-induced movement disorder characterized by muscle spasms. Dystonia commonly involves the musculature of the head and neck but may also include the extremities and trunk.
Symptoms may range from a mild subjective sensation of increased muscle tension to a life-threatening syndrome of severe muscle tetany and laryngeal dystonia (laryngospasm) with airway compromise.
The muscle spasms may lead to abnormal posturing of the head and neck with jaw muscle spasm. Spasm of the tongue leads to macroglossia and dysarthria; pharyngeal dystonia may produce impaired swallowing and drooling. Ocular muscle dystonia may produce oculogyric crisis.
Risk factors include use of high-potency antipsychotics; young men are at increased risk. The condition usually develops early in drug therapy (within days).
Treatment of dystonia depends on the severity of the symptoms. In the absence of laryngospasm or severe patient discomfort, intramuscular (1M) anticholinergic medication (benztropine or diphenhydramine) can be used. In more severe cases or if laryngospasm is present, IV anticholinergic medication is used. Some cases may require intubation if respiratory distress is severe. Discontinuation of the precipitating antipsychotic is sometimes necessary; in other cases, the addition of anticholinergic medications on a standing basis prevents the recurrence of dystonia.
Akathisia
Akathisia, a common side effect produced by antipsychotic medications, is also caused by serotonin reuptake inhibitors. Akathisia consists of a subjective sensation of inner restlessness or a strong desire to move one's body. Individuals with akathisia may appear anxious or agitated. They may pace or move about, unable to sit still. Akathisia can produce severe dysphoria and anxiety in patients and may drive them to become assaultive or to attempt suicide. It is important to accurately diagnose akathisia because if mistaken for agitation or worsening psychosis, antipsychotic dosage may be increased with resultant worsening of the akathisia.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Mental Health →
NewsToward an oral therapy for treating Alzheimer's disease: Using a cancer drug
Currently, no cure exists for Alzheimer's disease, the devastating neurological disease affecting more than 5 million Americans. But scientists are now reporting new progress on a set of compounds, initially developed…
24 July 2014
NewsMarijuana dependence alters the brain's response to drug paraphernalia
New research from The University of Texas at Dallas demonstrates that drug paraphernalia triggers the reward areas of the brain differently in dependent and non-dependent marijuana users. The study, published July 1 in…
16 July 2014
NewsHIV Drug Linked to Suicidality Risk
Initial HIV treatment with a widely used medication was associated with a small increase in the risk of suicidality in patients, researchers reported. An analysis of four large randomized trials of efavirenz (Sustiva)…





